It is an exciting time for the Life Sciences, which involves the living organisms and their structure, function, growth, origin, evolution, and distribution.

According to experts, the 21th Century belongs to “Life Sciences” and its expected growth. The growth around globe depends on the availability of well-trained scientists with expertise in such areas as microbiology, molecular genetics, biochemistry, bioprocess engineering, plant and animal cell culture technologies, metabolic engineering, biomaterials, macromolecular structure analysis, hybridoma technology, tissue engineering, and separation technologies. The biotechnology sector tend to be highly dynamic, research and investment intensive. In the past 10-12 years, this industry has experienced massive R & D expansion and technological development, which also extend to both core processes within R & D and the procurement processes.

There is also growing demand for new technologies in life sciences and healthcare, including public health. The recent decoding of the human genome is a major milestone in the history of medical sciences. More than three billion letters that form the genetic blueprint of human life are now mapped, allowing for the identification in the future of thousands of genes involved in disease-developing processes. This knowledge is expected to help diagnose potential risks for certain diseases much earlier and to uncover new ways to prevent and treat them. India has made rapid strides over the years. In addition, there is cross interaction across a number of disciplines, including biochemistry, bioengineering, cell biology, chemical engineering, genetics, microbiology, and pharmacology.

The Institute has clearly its focus set on developing new strategic growth opportunities and ideas in Life Sciences. The Institute believes in growing this complex area strategically.